
Adoram Therapeutics was selected to take part in a roadshow in Boston, USA, alongside nine other selected Swiss startups, providing a comprehensive deep dive into the east coast US biotech scene, with introductions to world class venture capital firms, local pharmaceutical companies and the broader biotech ecosystem. Co-CEO Dr. David Pejoski spent one week in Boston, followed by a networking week in New York.
